INSTYTUT PSYCHIATRII I NEUROLOGII

II KLINIKA NEUROLOGICZNA


NAJWAŻNIEJSZE PUBLIKACJE (W OSTATNICH 3 LATACH) ______________________________________________________

J. Seniów, M. Litwin, T. Litwin, M. Leśniak, A. Członkowska, New approach to the rehabilitation of post‑stroke focal cognitive syndrome: effect of levodopa combined with speech and language therapy on functional recovery from aphasia, J. Neurol. Sci. 2009, 283, 6, 214–218.

I. Kurkowska‑Jastrzębska, E. Bałkowiec‑Iskra, A. Ciesielska, I. Joniec, A. Cudna. M.M. Zaremba, A. Członkowski, A. Członkowska, Decreased inflammation and augmented expression of trophic factors correlate with MOG‑induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson’s disease, int. Immunopharmacol. 2009, 9, 781–791.

A. Kobayashi, J.M. Wardlow, R.I. Lindley, S.C. Lewis, P.A.G. Sandercock, A. Członkowska on behalf of the IST‑3 Collaborative Group, Oxfordshire community stroke project clinical stroke syndrome and appearances of tissue and vascular lesions on pretreatment CT in hyperacute ischemic stroke among the first 510 patients in the third international stroke trial (IST‑3), Stroke 2009, 40, 3, 743–748.

A. Członkowska, M. Niewada, I. Sarzyńska-Dugosz, A. Kobayashi, M. Skowrońska, Ten years of stroke programmes in Poland: Where did we start? Where did we get to?, Int. J. Stroke 2010, 5, 414-416.

A. Członkowska, I. Kurkowska-Jastrzębska, Inflammation and gliosis in neurological diseases – clinical implication, J. Neuroimmunol. 2011, 231, 78-85.

D. Mirowska-Guzel, G. Gromadzka, A. Mach, A. Członkowski, A. Członkowska, Association of IL1A. IL1B, ILRN, IL6, IL10 and TNF-alfa polymorphisms with risk and clinical course of multiple sclerosis in a Polish population, J. Neuroimmunol. 2011, 236, 87-92.

G. Gromadzka, M. Rudnicka, G. Chabik, A. Przybyłkowski, A. Członkowska, Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson’sdisease. J. Hepatology 2011, 55, 4, 913-919.

IST-3 callaborative group, P. Sandercock, JM Wardlaw, RI Lindley, M. Dennis, G. Cohen, G. Murray, K. Innes, G. Venables, A. Członkowska, A. Kobayashi, S. Ricci, V. Murray, E. Berge, KB Slot, GJ Hankey, M. Correia, A. Peeters, K. Matz, P. Lyrer, G. Gubitz, SJ Phillips, A. Arauz, The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial, Lancet, 2012, 23, 379, 2352-2363

P. Ferenci, A. Członkowska, W. Stremmel, R. Houwen, W. Rosenberg, M. Schilsky - European         Association for the Study of the Liver, EASL clinical practice guidelines: Wilson’s disease, J. Hepatology 2012, 56, 871- 85.